List of Denovo Biopharma patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11421280 Methods and composition for the prediction of the activity of enzastaurin	Patent 11421280 was granted and assigned to Denovo Biopharma on August, 2022 by the United States Patent and Trademark Office.	Denovo Biopharma	Denovo Biopharma	United States Patent and Trademark Office	11421280	August 23, 2022
‌ US Patent 11279949 Recombinant vectors comprising 2A peptide	Patent 11279949 was granted and assigned to Denovo Biopharma on March, 2022 by the United States Patent and Trademark Office.	Denovo Biopharma	Denovo Biopharma	United States Patent and Trademark Office	11279949	March 22, 2022
‌ US Patent 11230719 Retroviral vector having immune-stimulating activity	Patent 11230719 was granted and assigned to Denovo Biopharma on January, 2022 by the United States Patent and Trademark Office.	Denovo Biopharma	Denovo Biopharma	United States Patent and Trademark Office	11230719	January 25, 2022
‌ US Patent 11065311 Retroviral vector with mini-promoter cassette	Patent 11065311 was granted and assigned to Denovo Biopharma on July, 2021 by the United States Patent and Trademark Office.	Denovo Biopharma	Denovo Biopharma	United States Patent and Trademark Office	11065311	July 20, 2021
‌ US Patent 11060112 Producer cells for replication competent retroviral vectors	Patent 11060112 was granted and assigned to Denovo Biopharma on July, 2021 by the United States Patent and Trademark Office.	Denovo Biopharma	Denovo Biopharma	United States Patent and Trademark Office	11060112	July 13, 2021
‌ US Patent 11191764 Formulations of 5-fluorocytosine and uses thereof	Patent 11191764 was granted and assigned to Denovo Biopharma on December, 2021 by the United States Patent and Trademark Office.	Denovo Biopharma	Denovo Biopharma	United States Patent and Trademark Office	11191764	December 7, 2021